Neurotech International (ASX:NTI) Total Current Assets : A$5.07 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Neurotech International Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Neurotech International's total current assets for the quarter that ended in Dec. 2023 was A$5.07 Mil.

Neurotech International Total Current Assets Historical Data

The historical data trend for Neurotech International's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International Total Current Assets Chart

Neurotech International Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Current Assets

Get a 7-Day Free Trial

0.65

0.08

5.01

2.02

5.31

Neurotech International Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Current Assets	Get a 7-Day Free Trial										3.07	2.02	8.92	5.31	5.07

Neurotech International Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Neurotech International's Total Current Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	5.026	+	0.258	+	0.008	+	0.016
	=	5.31

Neurotech International's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	4.479	+	0.583	+	0.008	+	0
	=	5.07

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Neurotech International (ASX:NTI) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Neurotech International's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4.479	-	0.276	+	0.75 * 0.583	+	0.5 * 0.008
=	4.64

Neurotech International Total Current Assets Related Terms

Thank you for viewing the detailed overview of Neurotech International's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurotech International (ASX:NTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.neurotechinternational.com

Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend • 11-12-2014

By Dividend Dividend • 06-25-2013

9 Stocks with Double-Digit Yields and Buy or Better Recommendations

By Dividend Dividend • 07-17-2013

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend • 08-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson • 11-09-2013

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend • 01-17-2013

18 Stocks with Very High Yields (More Than 10%) and Earnings Growth

By Dividend Dividend • 12-20-2012